$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
BREAKING: Trump strikes major deal with UK on drug pricing
10:15am, Monday, 01'st Dec 2025
FOX Business White House correspondent Edward Lawrence reports the details of President Donald Trump's pharmaceutical deal with the U.K. on 'Varney & Co.'
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
10:46am, Friday, 28'th Nov 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AstraZeneca or Merck: Which Oncology Giant Has the Edge?
10:46am, Thursday, 27'th Nov 2025
AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
10:41am, Thursday, 27'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
12:18pm, Wednesday, 26'th Nov 2025
The IRA from 2022 allows the CMS to negotiate prices for a number of drugs each year for patients in Medicare. Late Tuesday, the agency announced newly negotiated prices for 15 blockbuster drugs from
AstraZeneca Wins FDA Nod For Imfinzi Combination Regimen In Tough-To-Treat Stomach Cancers
09:38am, Wednesday, 26'th Nov 2025
FDA approves AstraZeneca's Imfinzi plus FLOT for early gastric and GEJ cancers after Phase 3 data show strong event-free and overall survival benefits.
Boston Partners Sells 46,721 Shares of AstraZeneca PLC $AZN
05:14am, Wednesday, 26'th Nov 2025
Boston Partners trimmed its stake in AstraZeneca PLC (NASDAQ: AZN) by 0.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commiss
Medicare Announces Price Cuts For 15 Drugs— Novo Nordisk's Wegovy And Ozempic To Cost $274 A Month
05:11am, Wednesday, 26'th Nov 2025
The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its highest‑cost medications.
Aviso Financial Inc. Has $2.95 Million Position in AstraZeneca PLC $AZN
03:32am, Tuesday, 25'th Nov 2025
Aviso Financial Inc. lifted its holdings in shares of AstraZeneca PLC (NASDAQ: AZN) by 5.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange C
AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows
12:58pm, Monday, 24'th Nov 2025
Hong Kong-based Harbour BioMed announced on Sunday an update and advancement of its global strategic collaboration with AstraZeneca Plc (NASDAQ: AZN), initially established in March 2025.
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Nov. 23, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discove
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
08:22pm, Friday, 21'st Nov 2025
AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more.
Why AstraZeneca Stock Bumped Higher Today
06:23pm, Friday, 21'st Nov 2025
The pharmaceutical giant is plowing billions of dollars into expanding its drug-making capacity. It has ambitious plans for two facilities in Maryland.
AstraZeneca to invest $2 billion as part of US manufacturing push
02:05pm, Friday, 21'st Nov 2025
AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its previously announced $50 billion plan to expand manufacturing and research capabil
AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalyzing economic growth
02:05pm, Friday, 21'st Nov 2025
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its
Sign In
Buy AZN